Day: February 22, 2024

New Technology Solution Awards Categories for Artificial Intelligence

FAIRFAX, Va., Feb. 22, 2024 (GLOBE NEWSWIRE) — The Stevie^® Awards are now accepting nominations for The 21st Annual International Business Awards^®, the world’s premier business awards competition, attracting nominations from organizations in over 70 nations and territories each year.

All individuals and organizations worldwide—public and private, for-profit and non-profit, large and small—may submit nominations to The International Business Awards. The early-bird entry deadline, with reduced entry fees, is 10 April. The final entry deadline is 8 May, but late entries will be accepted through 12 June with payment of a late fee. Entry details are available at www.StevieAwards.com/IBA.

Juries featuring more than 150 executives worldwide will determine the Gold, Silver, and Bronze Stevie Award winners. Winners will be announced on 14 August and celebrated at a gala banquet in Europe this October (date and location to be confirmed).

The International Business Awards recognize achievement in every facet of the workplace. Categories include:

• Management Awards
• Sustainability Awards
• Entrepreneur of the Year Awards
• Company of the Year Awards
• Customer Service Awards
• Human Resources Awards
• Marketing Awards
• New Product Awards
• Corporate Communications and Public Relations Awards
• Website, App, Event, Video, and other Media Awards
• Social Media Awards
• Technology Awards
• Thought Leadership Awards

There are many new and revised features of The International Business Awards for 2024:

• There are a variety of new Technology Solution Categories for Artificial Intelligence and Machine Learning Solutions, split into subcategories for Financial, Generative (audio, graphics, text, video), Healthcare, and other solutions. There are additional new technology categories for Cybersecurity, Digital Asset Management, Digital Employee Experience, and Knowledge Center/Help Sites.
• There are many new Event Categories for Cause & Green Events including CSR Experience, Employee Giving & Volunteerism, Inclusive Events, and other Brand Experiences/Events by type including Gamified Experience, Pop-Up Experience, and Immersive Experience.
• There are new categories sprinkled throughout the category groups for New Product & Product Management Awards, Mobile Site & App Awards, and Website Awards.

Stevie Award winners in the 2023 IBAs included Ayala Land Inc. (Philippines), Anexa BPO (Mexico), Empire Eagle Food (Taiwan), EY Global Services Limited (USA), IBM Corporation (Worldwide), LLYC (Spain), Ooredoo Group (Qatar), Saudi Aramco (Saudi Arabia), TalkLife (United Kingdom), Turkish Aerospace (Turkey), HALKBANK (Turkey), The Dubai Digital Authority (United Arab Emirates), Viettel Group (Vietnam), and many more.

About the Stevie Awards
Stevie Awards are conferred in eight programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Great Employers, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.

Contact:
Nina Moore
+1 (703) 547-8389
Nina@StevieAwards.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bfd82c2d-0486-47b4-8122-630fc25eb97c

GlobeNewswire Distribution ID 9040884

Percepxion comes pre-configured in Lantronix’s gateways, routers, trackers and switches to accelerate IoT edge device deployments

IRVINE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions, today announced Percepxion, its new Cloud IoT Edge Solutions platform. Percepxion is pre-configured into Lantronix’s award-winning IoT gateways, routers, trackers and switches to provide secure, comprehensive device lifecycle management. The Percepxion platform efficiently scales edge deployments from regional to global and is managed through an intuitive single pane of glass.

“The Percepxion platform provides our customers with an easy-to-deploy IoT solution that comes pre-configured on our connect and compute products,” said Jacques Issa, vice president of Marketing at Lantronix Inc. “Percepxion’s multi-tenant feature enables a B2B solution, generating incremental revenue streams for our end customers.”

Remote installation of Lantronix devices includes zero-touch automated provisioning managed through Percepxion. Site-required firmware, configuration and certificates are remotely loaded to ensure secure data communication and compliant devices. It is ideal for critical infrastructure management, fleet management, smart cities and other end-to-end IoT edge solutions.

Key Percepxion features include:

• Robust Security. Percepxion simplifies software updates for maintaining robust device cybersecurity. The cloud platform complies with complex security requirements from corporate security offices for devices, data access and users, ensuring integrity and confidentiality across entire solutions.
• Real-Time Device Operation. Percepxion enables real-time remote access for diagnosing and troubleshooting as well as over-the-air updates with select grouping and automated monitoring that generate alerts and notifications to minimize system downtime.
• Powerful Data Integration and Analysis. Percepxion’s custom dashboards provide on-demand visibility of device telemetry data. Trend analysis provides edge insights to improve efficiency and create predictive maintenance applications. Enterprise use cases can access data using Percepxion API services for headless operation.

Percepxion’s holistic approach to IoT edge solutions accelerates time to revenue by simplifying edge management and maintenance while providing customers with assistance and long-term assurance.

The Percepxion Service for Lantronix Devices

Delivered as a service, the Percepxion multi-tenant cloud platform provides businesses with comprehensive device lifecycle management through Web and mobile apps. It is offered with bundled Level Technical Support, limited warranty and other optional services

To learn more about Percepxion and review the 60-day free trial offer, visit https://www.lantronix.com/percepxion/.

About Lantronix

Lantronix Inc. is a global provider of compute and connectivity IoT solutions that target high-growth industries including Smart Cities, Automotive and Enterprise. Lantronix’s products and services empower companies to achieve success in the growing IoT markets by delivering customizable solutions that address each layer of the IoT Stack. Lantronix’s leading-edge solutions include Intelligent Substations infrastructure, Infotainment systems and Video Surveillance, supplemented with advanced Out-of-Band Management (OOB) for Cloud and Edge Computing.

For more information, visit the Lantronix website.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in this news release that are not entirely historical and factual in nature, including without limitation statements related to our solutions, technologies and products and expectations regarding our management and our future growth and profitability. These forward-looking statements are based on our current expectations and are subject to substantial risks and uncertainties that could cause our actual results, future business, financial condition, or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this news release. The potential risks and uncertainties include, but are not limited to, such factors as the effects of negative or worsening regional and worldwide economic conditions or market instability on our business, including effects on purchasing decisions by our customers; our ability to mitigate any disruption in our and our suppliers’ and vendors’ supply chains due to the COVID-19 pandemic or other outbreaks, wars and recent tensions in Europe, Asia and the Middle East, or other factors; future responses to and effects of public health crises; cybersecurity risks; changes in applicable U.S. and foreign government laws, regulations, and tariffs; our ability to successfully implement our acquisitions strategy or integrate acquired companies; difficulties and costs of protecting patents and other proprietary rights; the level of our indebtedness, our ability to service our indebtedness and the restrictions in our debt agreements; and any additional factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023, filed with the Securities and Exchange Commission (the “SEC”) on Sept. 12, 2023, including in the section entitled “Risk Factors” in Item 1A of Part I of such report, as well as in our other public filings with the SEC. Additional risk factors may be identified from time to time in our future filings. The forward-looking statements included in this release speak only as of the date hereof, and we do not undertake any obligation to update these forward-looking statements to reflect subsequent events or circumstances.

© 2024 Lantronix, Inc. All rights reserved. Lantronix is a registered trademark. Other trademarks and trade names are those of their respective owners.

Lantronix Media Contact:
Gail Kathryn Miller
Corporate Marketing &
Communications Manager
media@lantronix.com
949-212-0960

Lantronix Analyst and Investor Contact:
Jeremy Whitaker
Chief Financial Officer
investors@lantronix.com
949-450-7241

GlobeNewswire Distribution ID 9041031

Le redimensionnement de la pharmacie spécialisée non commerciale de Fortrea apporte des solutions flexibles et évolutives à ses clients, et permet de délivrer des médicaments révolutionnaires directement aux patients

DURHAM, État de Caroline du Nord, 21 févr. 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq : FTRE), ci-après la « Société », une organisation de recherche contractuelle (ou CRO, de l’anglais Contract Research Organization) mondiale de premier plan, annonce ce jour l’ouverture de FortreaRx, une pharmacie spécialisée non commerciale de grande surface dans la ville de Lake Mary, en Floride. L’établissement se spécialise dans les solutions avancées d’accès aux patients à travers les États-Unis, et intègre une expertise en produits de la chaîne du froid et à température ambiante assortie de capacités de distribution.

FortreaRx est agréée dans 50 États et territoires américains. Ses solutions flexibles et évolutives visent à répondre aux besoins spécifiques de ses clients, tout en délivrant des médicaments aux patients qui pourraient en être autrement privés. À l’image de FortreaRx, les pharmacies spécialisées non commerciales sont au service d’une clientèle spécialisée en fabrication pharmaceutique. Elles sont essentielles pour assurer le lien entre les industriels et les patients répondant à leurs critères en matière d’aide à la prescription.

Depuis la création de FortreaRx fin 2008, Fortrea a innové dans le champ des services de pharmacie spécialisée non commerciale en se concentrant exclusivement sur la distribution de produits gratuits intégrée au cœur des programmes d’aide aux patients (ou PAP, de l’anglais Patient Assistance Programs) parrainés par les acteurs de l’industrie pharmaceutique, et visant à développer l’accès aux soins pour les patients qualifiés sous-assurés ou n’ayant pas d’assurance santé. Avec ses 3 716 mètres carrés, FortreaRx double la surface de son espace opérationnel et renforce ses capacités, notamment :

• 167 mètres carrés dédiés au stockage de produits à température ambiante
• Plus de 557 mètres carrés dédiés au stockage de produits de la chaîne du froid, à savoir que plus de 85 % des ordonnances à la main de FortreaRx sont concernées par cette caractéristique
• Un espace de traitement et d’exécution des commandes agrandi pour absorber jusqu’à 18 000 ordonnances par jour
• De meilleures modalités d’expédition, assorties d’options de livraison du jour au lendemain, accélérée ou sous 2 jours

Bill Nolan, vice-président et responsable mondial de la branche Accès aux patients chez Fortrea, observe que « Combinées à la nouvelle dimension de FortreaRx, nos offres de services aux patients bien établies s’entendent désormais de bout en bout, des premières démarches cliniques à la mise en marché et jusqu’à la livraison, garantissant ainsi une expérience globale et personnalisée pour les patients. De notre vaste expertise thérapeutique à notre engagement indéfectible envers l’aide aux patients, Fortrea brille dans la conception de solutions pertinentes et ciblées sur les besoins de nos promoteurs pharmaceutiques en s’efforçant de réduire les enjeux auxquels font face patients et fournisseurs via la simplification du processus de candidature et la pleine intégration d’initiatives d’aide au sens large aux patients ».

Animée par des gestionnaires de cas, la centrale d’appels de FortreaRx gère en toute transparence les demandes des patients, le volet conseil et la vérification des ordonnances. L’équipe Fortrea dédiée à l’accès aux soins aide patients et fournisseurs à comprendre et résoudre les complexités du principe de couverture tout en levant, pour les patients, les barrières de l’accès aux médicaments.

Les solutions FortreaRx constituent une réponse efficace, consultative et économique aux programmes de prescription des industriels pharmaceutiques. Elles représentent habituellement d’importantes économies annuelles pour les patients.

Pour en savoir plus sur FortreaRx et sa gamme de services, rendez-vous sur : Fortrea.com.

À propos de Fortrea

Fortrea (Nasdaq : FTRE) figure parmi les principaux fournisseurs de solutions de développement clinique et d’accès aux soins pour les patients dans le secteur mondial des sciences de la vie. Fortrea s’associe à des sociétés établies et émergentes du domaine biopharmaceutique, des dispositifs médicaux et des diagnostics pour stimuler l’innovation en matière de santé, et accélérer la mise au point de traitements révolutionnaires pour les patients qui en ont besoin. Nous proposons des services de gestion d’essais cliniques de phase I à IV, de pharmacologie clinique, d’essais différenciés axés sur des technologies habilitantes, et des services post-autorisation. Nos solutions s’appuient sur 30 ans d’expérience dans 20 domaines thérapeutiques, une passion pour la rigueur scientifique, des connaissances exceptionnelles et un solide réseau de centres de recherche. Notre équipe talentueuse et diversifiée d’environ 19 000 collaborateurs répartis sur plus de 90 pays est dimensionnée pour fournir des solutions ciblées et agiles à nos clients, partout dans le monde. Pour en savoir plus sur la manière dont Fortrea est moteur d’influence du pipeline au patient, rendez-vous sur Fortrea.com et suivez-nous sur LinkedIn et X (anciennement Twitter) @Fortrea.

Coordonnées :
Relations médias auprès de Fortrea : Galen Wilson – 703-298-0802, media@fortrea.com
Relations médias auprès de Fortrea : Kate Dillon – 646-818-9115, kdillon@prosek.com

GlobeNewswire Distribution ID 9041107

Expansão de farmácias especializadas não comerciais da Fortrea oferece soluções flexíveis e escaláveis para clientes e medicamentos que mudam as vidas diretamente para pacientes

DURHAM, N.C., Feb. 21, 2024 (GLOBE NEWSWIRE) — A Fortrea (Nasdaq: FTRE) (a “Empresa”), organização líder global de pesquisa por contrato (CRO), anunciou hoje a inauguração da sua farmácia especializada não comercial expandida, FortreaRx, em Lake Mary, Flórida, que oferece soluções avançadas de acesso de pacientes nos Estados Unidos, incluindo recursos e experiência de distribuição de cadeia fria e ambiente.

Licenciada em todos os 50 estados e territórios dos EUA, a FortreaRx oferece soluções flexíveis e escaláveis que atendem às necessidades específicas dos seus clientes, fornecendo medicamentos a pacientes que, de outra forma, não teriam acesso a eles. As farmácias especializadas não comerciais, como a FortreaRx, fornecem essas soluções em nome dos seus clientes fabricantes de produtos farmacêuticos, estando posicionadas de forma única para servir como uma ponte entre os fabricantes de produtos farmacêuticos e os pacientes que atendam aos requisitos do fabricante para assistência médica.

Desde o lançamento da FortreaRx no final de 2008, a Fortrea tem sido pioneira em serviços de farmácias especializadas não comerciais, concentrando-se exclusivamente na distribuição de produtos gratuitos como um componente integrado de programas de assistência ao paciente (PAP) patrocinados por fabricantes farmacêuticos, projetados para expandir o acesso à terapia para pacientes qualificados sem plano de saúde ou subsegurados. A FortreaRx, com 40.000 pés quadrados, tem o dobro do seu espaço operacional e reforça seus recursos, oferecendo:

• 1.800 pés quadrados de armazenamento ambiente
• Mais de 6.000 pés quadrados de armazenamento em cadeia fria, com mais de 85% das prescrições aviadas pela FortreaRx exigindo esse manuseio exclusivo
• Maior espaço de processamento e atendimento para até 18.000 prescrições diárias
• Soluções de envio aprimoradas com opções de entregas noturnas, aceleradas e de 2 dias

“As ofertas bem estabelecidas de serviços ao paciente da Fortrea, juntamente com os recursos expandidos da FortreaRx, oferecem uma abordagem completa, desde os estágios clínicos iniciais até a entrega pós-comercialização, garantindo uma experiência abrangente e personalizada para os pacientes”, disse Bill Nolan, vice-presidente e chefe global de Acesso ao Paciente da Fortrea. “Com a nossa experiência em estados de doença de ampla gama até o nosso compromisso inabalável com a assistência ao paciente, a Fortrea se destaca na entrega de soluções oportunas e impactantes aos nossos patrocinadores farmacêuticos que se esforçam para reduzir os desafios dos pacientes e provedores, simplificando os processos de inscrição e oferecendo total integração com iniciativas mais amplas de suporte ao paciente.”

O centro de gerentes de casos do call center da FortreaRx gerencia integralmente consultas de pacientes, aconselhamento e verificação de dados de prescrições. A equipe de acesso ao paciente da Fortrea ajuda os pacientes e provedores a entenderem e navegarem nas complexidades da cobertura, removendo os obstáculos para levar a medicação aos pacientes.

A FortreaRx oferece soluções eficientes, consultivas e econômicas para programas de prescrição do fabricante, normalmente resultando em economias anuais significativas para os pacientes.

Para mais informações sobre a FortreaRx e seus serviços, visite Fortrea.com.

Sobre a Fortrea

A Fortrea (Nasdaq: FTRE) é fornecedora líder global de soluções para o desenvolvimento clínico e acesso ao paciente para a indústria de ciências da vida. Fazemos parcerias com grandes e emergentes empresas biofarmacêuticas, de dispositivos médicos e de diagnóstico para impulsionar a inovação na saúde que acelera terapias que mudam a vida dos pacientes que precisam delas. A Fortrea fornece gerenciamento de testes clínicos de fase I-IV, farmacologia clínica, soluções de testes com tecnologia diferenciada e serviços pós-aprovação. As soluções da Fortrea utilizam suas três décadas de experiência abrangendo mais de 20 áreas terapêuticas, sua dedicação ao rigor científico, insights excepcionais e uma forte rede de pesquisadores. Nossa equipe talentosa e diversificada de aproximadamente 19.000 pessoas que trabalham em mais de 90 países é dimensionada para fornecer soluções focadas e ágeis para clientes de todo o mundo. Saiba mais sobre como a Fortrea está se tornando uma força transformadora de pipeline para paciente na Fortrea.com e siga-nos no LinkedIn e X (antigo Twitter) @Fortrea.

Contatos da Fortrea:
Fortrea para Mídia: Galen Wilson – 703-298-0802, media@fortrea.com
Fortrea Media: Kate Dillon – 646-818-9115, kdillon@prosek.com

GlobeNewswire Distribution ID 9041107